va111913
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00769964)
Timeline
Indications
Studied for
Mechanism of action
- Vasopressin V1a receptorANTAGONIST
AVPR1A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- va111913
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00963053 | Phase 2 | Aug 1, 2009 | Bio-Kinetic Clinical Applications, Jean Brown Research, Pivotal Research Centers, Premier Research Group, Vantia Ltd |
| NCT00769964 | Phase 1 | Sep 1, 2008 | Vantia Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vantia Ltd | For profit | 2 | 2 | 2 | 2008 |
| Bio-Kinetic Clinical Applications | For profit | 1 | 0 | 1 | 2009 |
| Jean Brown Research | For profit | 1 | 0 | 1 | 2009 |
| Pivotal Research Centers | For profit | 1 | 0 | 1 | 2009 |
| Premier Research Group | For profit | 1 | 0 | 1 | 2009 |
5 organizations
Page 1 / 1